ROYALTY PHARMA PLC- CL A (RPRX) Stock Analyst Earnings Estimates
NASDAQ:RPRX - Nasdaq - GB00BMVP7Y09 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 2.29B 7.87% | 2.237B -2.28% | 2.355B 5.25% | 2.697B 14.54% | 2.992B 10.94% | 3.23B 7.95% | 2.751B -14.83% | 2.882B 4.76% | 2.989B 3.71% | 3.086B 3.25% | 3.221B 4.37% | 3.318B 3.01% | |
| EBITDA YoY % growth | N/A 20.16% | N/A 31.88% | N/A 7.26% | 2.542B -8.92% | 2.861B 12.55% | 3.105B 8.53% | 3.602B 16.01% | 3.997B 10.97% | 4.266B 6.73% | 4.515B 5.84% | 4.597B 1.82% | 4.857B 5.66% | |
| EBIT YoY % growth | 1.431B -13.84% | 922.9M -35.49% | 1.492B 61.68% | 2.197B 47.24% | 2.507B 14.11% | 2.631B 4.95% | 2.306B -12.35% | 2.406B 4.34% | 2.474B 2.83% | 2.544B 2.83% | 2.655B 4.36% | 2.713B 2.18% | |
| Operating Margin | 62.49% | 41.25% | 63.37% | 81.46% | 83.79% | 81.46% | 83.82% | 83.48% | 82.77% | 82.44% | 82.43% | 81.77% | |
| EPS YoY % growth | 2.23 -10.34% | 3.67 64.57% | 4.38 19.35% | 4.05 -7.59% | 4.50 11.23% | 4.92 9.31% | 6.18 25.61% | 8.16 32.01% | 8.48 3.88% | 8.80 3.85% | N/A | N/A |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | 0.99 -14.12% | 1.09 10.95% | 1.10 14.33% | 1.18 17.08% | 1.58 60.39% |
| Revenue Q2Q % growth | 630.3M 5.76% | 706.37M 24.36% | 690.23M 13.52% | 733.8M 29.88% | N/A |
| EBITDA Q2Q % growth | 583.93M -10.05% | 707.68M 8.82% | 623.73M 7.05% | 756.08M 14.86% | 822.12M 40.79% |
| EBIT Q2Q % growth | 594.82M -2.95% | 582.46M 889.52% | 567.85M 110.60% | 708.81M -3.57% | 796.62M 33.93% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | 1.01 27.85% | 0.95 | 0.06 | 6.65% |
| Q2 2024 Q2Q % growth | 0.96 14.29% | 0.98 | -0.02 | -2.47% |
| Q1 2024 Q2Q % growth | 0.98 -38.75% | 1.00 | -0.02 | -2.16% |
| Q4 2023 Q2Q % growth | 1.15 -26.28% | 1.03 | 0.12 | 11.63% |
| Q3 2023 Q2Q % growth | 0.79 9.72% | 0.77 | 0.02 | 2.45% |
| Q2 2023 Q2Q % growth | 0.84 6.33% | 0.82 | 0.02 | 1.92% |
| Q1 2023 Q2Q % growth | 1.60 166.67% | 1.30 | 0.30 | 23.19% |
| Q4 2022 Q2Q % growth | 1.56 95.00% | 1.50 | 0.06 | 3.86% |
| Q3 2022 Q2Q % growth | 0.72 323.53% | 0.73 | -0.01 | -1.45% |
| Q2 2022 Q2Q % growth | 0.79 -26.85% | 0.80 | -0.01 | -0.86% |
| Q1 2022 Q2Q % growth | 0.60 233.33% | 0.75 | -0.15 | -19.60% |
| Q4 2021 Q2Q % growth | 0.80 185.71% | 0.79 | 0.01 | 1.20% |
| Q3 2021 Q2Q % growth | 0.17 -64.58% | 0.71 | -0.54 | -75.92% |
| Q2 2021 Q2Q % growth | 1.08 47.95% | 0.71 | 0.37 | 52.35% |
| Q1 2021 Q2Q % growth | 0.18 | 0.66 | -0.48 | -72.85% |
| Q4 2020 Q2Q % growth | 0.28 | 0.71 | -0.43 | -60.46% |
| Q3 2020 Q2Q % growth | 0.48 | 0.60 | -0.12 | -20.46% |
| Q2 2020 Q2Q % growth | 0.73 | 0.62 | 0.11 | 17.60% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | 565M 5.35% | 710.02M | -145.02M | -20.42% |
| Q2 2024 Q2Q % growth | 608M 13.01% | 641.1M | -33.1M | -5.16% |
| Q1 2024 Q2Q % growth | 568M -16.96% | 676.48M | -108.48M | -16.04% |
| Q4 2023 Q2Q % growth | 596M 5.36% | 705.48M | -109.48M | -15.52% |
| Q3 2023 Q2Q % growth | 536.313M -6.48% | 630.35M | -94.037M | -14.92% |
| Q2 2023 Q2Q % growth | 538M 0.37% | 547.32M | -9.32M | -1.70% |
| Q1 2023 Q2Q % growth | 684M 21.71% | 869.96M | -185.96M | -21.38% |
| Q4 2022 Q2Q % growth | 565.7M -1.74% | 970.32M | -404.62M | -41.70% |
| Q3 2022 Q2Q % growth | 573.5M -2.10% | 598.92M | -25.42M | -4.24% |
| Q2 2022 Q2Q % growth | 536M -3.42% | 553.02M | -17.02M | -3.08% |
| Q1 2022 Q2Q % growth | 562M -1.92% | 611.75M | -49.75M | -8.13% |
| Q4 2021 Q2Q % growth | 575.7M 0.63% | 567.42M | 8.28M | 1.46% |
| Q3 2021 Q2Q % growth | 585.8M 8.80% | 584.26M | 1.54M | 0.26% |
| Q2 2021 Q2Q % growth | 555M 8.63% | 528.25M | 26.75M | 5.06% |
| Q1 2021 Q2Q % growth | 573M 14.39% | 519.89M | 53.11M | 10.22% |
| Q4 2020 Q2Q % growth | 572.1M 25.05% | 490.33M | 81.77M | 16.68% |
| Q3 2020 Q2Q % growth | 538.4M 15.96% | 462.23M | 76.17M | 16.48% |
| Q2 2020 Q2Q % growth | 510.9M 11.65% | 478.34M | 32.56M | 6.81% |
| Q1 2020 Q2Q % growth | 500.9M 15.18% | % |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | -2.02% | -8.36% | 0.32% | 0.9% |
| Revenue | 4.38% | -2.11% | 2.08% | -0.22% |